PT  - JOURNAL ARTICLE
AU  - Mario Coccia
TI  - THE IMPACT OF LOCKDOWN ON PUBLIC HEALTH DURING THE FIRST WAVE OF COVID-19 PANDEMIC: LESSONS LEARNED FOR DESIGNING EFFECTIVE CONTAINMENT MEASURES TO COPE WITH SECOND WAVE
AID  - 10.1101/2020.10.22.20217695
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.22.20217695
4099  - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20217695.short
4100  - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20217695.full
AB  - What is hardly known in the studies of the COVID-19 global pandemic crisis is the impact of general lockdown during the first wave of COVID-19 pandemic both public health and economic system. The main goal of this study is a comparative analysis of some European countries with a longer and shorter period of national lockdown during the first wave of COVID-19 from March to August 2020. Findings suggests that: a) countries with shorter period of lockdown have a variation of confirmed cases/population (%) higher than countries with longer period of lockdown; b) countries with shorter period of lockdown have average fatality rate (5.45%) lower than countries with longer period of lockdown (12.70%), whereas variation of fatality rate from August to March 2020 suggests a higher reduction in countries with longer period of lockdown (−1.9% vs 0.72%). However, Independent Samples Test and the Mann-Whitney test reveal that the effectiveness of longer period of lockdown versus shorter one on public health is not significant. In addition, the COVID-19 pandemic associated with longer period of lockdown has a higher negative impact on economic growth with consequential social issues in countries. Results of the impact of COVID-19 lockdowns on public health and economies of some leading countries in Europe, during the first wave of the COVID-19 pandemic, can provide vital information to design effective containment strategies in future waves of this pandemic to minimize the negative effects in society.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study does not involve human subjects and/or animals for scientific research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe availability of all data is indicated in references. https://ec.europa.eu/eurostat/databrowser/view/namq_10_gdp/default/table?lang=en https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6